Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma
Clinical trial NCT01716754 · COMPLETED
Trial details
- NCT number
- NCT01716754
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2016-01-01
- Enrollment
- 471
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.